Literature DB >> 4005670

Availability of dantrolene in Canadian hospitals.

P G Duncan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4005670     DOI： 10.1007/bf03015127

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN： 0008-2856


× No keyword cloud information.
  4 in total

1.  Dantrolene dose response in awake man: implications for management of malignant hyperthermia.

Authors:  E H Flewellen; T E Nelson; W P Jones; J F Arens; D L Wagner
Journal:  Anesthesiology       Date:  1983-10       Impact factor: 7.892

Review 2.  Dantrolene.

Authors:  B A Britt
Journal:  Can Anaesth Soc J       Date:  1984-01

Review 3.  Current concepts. The malignant hyperthermia syndrome.

Authors:  T E Nelson; E H Flewellen
Journal:  N Engl J Med       Date:  1983-08-18       Impact factor: 91.245

4.  Dantrolene in human malignant hyperthermia.

Authors:  M E Kolb; M L Horne; R Martz
Journal:  Anesthesiology       Date:  1982-04       Impact factor: 7.892
  4 in total
  2 in total

1.  The anaesthetic management of the malignant hyperthermia susceptible parturient.

Authors:  M J Douglas; G H McMorland
Journal:  Can Anaesth Soc J       Date:  1986-05

2.  Availability of dantrolene in Canadian hospitals.

Authors:  R Paasuke; A K Brownell
Journal:  Can Anaesth Soc J       Date:  1985-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.